Given the feed-forward loop linking SIRT1 and HSP90α, we hypothesized that simultaneous blocking of SIRT1 and HSP90 activity would exhibit synergistic effects in targeting the OxPhos-DLBCL cells. Here, SIRT1 is linked to diffuse large B-cell lymphoma.